Key facts
- Solis Agrosciences’s last known valuation is $12.8M (Jul 2025).
- It has raised $9.4M across 1 recorded rounds; the latest was Seed Round ($3.1M) in Nov 2022.
- Notable investors include Cultivation Capital, BioGenerator Ventures, Missouri Technology Corporation, Herman Capital Management, Jim McKelvey.
- Solis Agrosciences has filed 1 Form D with the SEC, most recently Dec 2022 ($3.1M sold to 14 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Solis Agrosciences
Funding rounds
1 roundsAbout Solis Agrosciences
Developer of a biotechnology research designed to support the creation and advancement of improved crop traits through gene editing and genomic analysis. The company offers comprehensive research services, including molecular design, gene editing, plant growth assessment and sequencing, enabling agricultural technology innovators, crop scientists and research organizations to accelerate agricultural research and bring new crop innovations closer to practical use.
- Sector
- Materials and Resources
- HQ
- Saint Louis, MO, United States
- Founded
- 2021
- Employees
- 27
- Website
- solisagrosciences.com/
- Ownership
- Privately Held (backing)
Solis Agrosciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Solis Agrosciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Solis Agrosciences in its N-PORT filings yet. We sweep new filings monthly.